Tectonic Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
GA
WCM
AIP
AP
HCM
CNB
Tectonic Advisors's REGN Position: Q2 2026 in Review
Tectonic Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 0.53% in Q2 2026, selling an estimated $4.08K and leaving 1,126 shares worth $702K. The position accounts for 0.03% of the portfolio, ranked #219.
Tectonic Advisors first reported a position in REGN in Q4 2020 and has held it in 20 quarters since. The position peaked at $882K in Q4 2025. 208 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Tectonic Advisors held 1,126 shares of Regeneron Pharmaceuticals worth $702K as of Q2 2026.
- Tectonic Advisors sold 6 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.08K.
- Regeneron Pharmaceuticals made up 0.03% of Tectonic Advisors's portfolio in Q2 2026, its #219 holding.
- Tectonic Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
- Tectonic Advisors's Regeneron Pharmaceuticals position peaked at $882K in Q4 2025.
- 208 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Tectonic Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.